A Case of Possibly Pathogenic R62C Mutation in a Patient with Probable Early-onset Alzheimer's Dementia Supported by Structure Prediction

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2017 Mar 1

PMID 28243073

Citations 3

Authors

Kyung Won Park

Seong Soo An

Eva Bagyinszky

SangYun Kim

Affiliations

Soon will be listed here.

Abstract

A 49-year-old Korean male patient with dementia was diagnosed with probable early-onset Alzheimer's disease (AD). He presented with memory problems, personality changes, and disorientation. His family history of dementia was probably negative, since no family member with dementia was found or mentioned. Mild cortical atrophy was observed upon magnetic resonance imaging analyses of his brain, and the single-photon emission computed tomography analysis revealed hypoperfusion in the frontal, temporal, and limbic lobes. The patient was tested for mutations in , , , , , and genes. Genetic analysis revealed R62C mutation in gene. R62C mutation was previously reported in European populations, including Dutch and Belgian families with AD. Herein, we present the first case report of R62C mutation in Asia. PolyPhen-2 and SIFT software analyses predicted this mutation as "possibly damaging", suggesting its potential involvement with AD. In silico protein structural prediction analyses of R62 and C62 revealed two divergent structures, suggesting that large perturbations of R62C mutation might cause dysfunctions of , which may alter the normal amyloid production.

Citing Articles

PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.

Dong L, Liu C, Sha L, Mao C, Li J, Huang X J Alzheimers Dis. 2022; 87(4):1549-1556.

PMID: 35491795 PMC: 9277672. DOI: 10.3233/JAD-220194.

A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease.

Guven G, Samanci B, Gulec C, Hanagasi H, Gurvit H, Gokalp E Neurol Sci. 2021; 42(6):2497-2504.

PMID: 33855622 DOI: 10.1007/s10072-021-05243-w.

A pathogenic p.His169Asn mutation associated with early-onset Alzheimer's disease.

Giau V, Pyun J, Bagyinszky E, An S, Kim S Clin Interv Aging. 2018; 13:1321-1329.

PMID: 30104866 PMC: 6074827. DOI: 10.2147/CIA.S170374.

References

Dobricic V, Stefanova E, Jankovic M, Gurunlian N, Novakovic I, Hardy J . Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort. Neurobiol Aging. 2012; 33(7):1481.e7-12. DOI: 10.1016/j.neurobiolaging.2011.12.007. View

Binetti G, Signorini S, Squitti R, Alberici A, Benussi L, Cassetta E . Atypical dementia associated with a novel presenilin-2 mutation. Ann Neurol. 2003; 54(6):832-6. DOI: 10.1002/ana.10760. View

Kamimura K, Tanahashi H, Yamanaka H, Takahashi K, Asada T, Tabira T . Familial Alzheimer's disease genes in Japanese. J Neurol Sci. 1998; 160(1):76-81. DOI: 10.1016/s0022-510x(98)00219-6. View

Blauwendraat C, Wilke C, Jansen I, Schulte C, Simon-Sanchez J, Metzger F . Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants. Neurobiol Aging. 2015; 37:208.e11-208.e17. DOI: 10.1016/j.neurobiolaging.2015.09.016. View

Ertekin-Taner N, Younkin L, Yager D, Parfitt F, Baker M, Asthana S . Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology. 2007; 70(8):596-606. DOI: 10.1212/01.WNL.0000278386.00035.21. View

Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D . Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006; 442(7105):920-4. DOI: 10.1038/nature05017. View

Schellenberg G, Pericak-Vance M, Wijsman E, Moore D, Gaskell Jr P, Yamaoka L . Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am J Hum Genet. 1991; 48(3):563-83. PMC: 1682988. View

Sala Frigerio C, Lau P, Troakes C, Deramecourt V, Gele P, Van Loo P . On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients. Alzheimers Dement. 2015; 11(11):1265-76. DOI: 10.1016/j.jalz.2015.02.007. View

Walker E, Martinez M, Brunkan A, Goate A . Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios. J Neurochem. 2005; 92(2):294-301. DOI: 10.1111/j.1471-4159.2004.02858.x. View

10.

Bagyinszky E, Youn Y, An S, Kim S . The genetics of Alzheimer's disease. Clin Interv Aging. 2014; 9:535-51. PMC: 3979693. DOI: 10.2147/CIA.S51571. View

11.

Rizzu P, van Swieten J, Joosse M, Hasegawa M, Stevens M, Tibben A . High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet. 1999; 64(2):414-21. PMC: 1377751. DOI: 10.1086/302256. View

12.

Shi Z, Wang Y, Liu S, Liu M, Liu S, Zhou Y . Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations. Dement Geriatr Cogn Disord. 2014; 39(1-2):32-40. DOI: 10.1159/000366272. View

13.

Niu F, Yu S, Zhang Z, Yi X, Ye L, Tang W . Novel mutation in the PSEN2 gene (N141Y) associated with early-onset autosomal dominant Alzheimer's disease in a Chinese Han family. Neurobiol Aging. 2014; 35(10):2420.e1-5. DOI: 10.1016/j.neurobiolaging.2014.04.011. View

14.

Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania F, Mitra R . Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One. 2012; 7(2):e31039. PMC: 3270040. DOI: 10.1371/journal.pone.0031039. View

15.

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-9. PMC: 2855889. DOI: 10.1038/nmeth0410-248. View

16.

To M, Gokgoz N, Doyle T, Donoviel D, Knight J, Hyslop P . Functional characterization of novel presenilin-2 variants identified in human breast cancers. Oncogene. 2006; 25(25):3557-64. DOI: 10.1038/sj.onc.1209397. View

17.

Sleegers K, Roks G, Theuns J, Aulchenko Y, Rademakers R, Cruts M . Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain. 2004; 127(Pt 7):1641-9. DOI: 10.1093/brain/awh179. View

18.

Piscopo P, Marcon G, Piras M, Crestini A, Campeggi L, Deiana E . A novel PSEN2 mutation associated with a peculiar phenotype. Neurology. 2008; 70(17):1549-54. DOI: 10.1212/01.wnl.0000310643.53587.87. View

19.

Kallberg M, Wang H, Wang S, Peng J, Wang Z, Lu H . Template-based protein structure modeling using the RaptorX web server. Nat Protoc. 2012; 7(8):1511-22. PMC: 4730388. DOI: 10.1038/nprot.2012.085. View

20.

Youn Y, Bagyinszky E, Kim H, Choi B, An S, Kim S . Probable novel PSEN2 Val214Leu mutation in Alzheimer's disease supported by structural prediction. BMC Neurol. 2014; 14:105. PMC: 4036836. DOI: 10.1186/1471-2377-14-105. View